Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC40 is a large protein (over 1,100 amino acids) encoded on human chromosome 17[2]. It contains extensive coiled-coil domains essential for the structural regulation of motile cilia. The protein is specifically expressed in tissues rich in motile cilia, such as the respiratory tract and reproductive system[8]. Its primary role is to facilitate proper assembly of the inner dynein arms and dynein regulatory complexes within the axoneme, the core skeletal structure of cilia and flagella[1][2][3][4][5]. Defective CCDC40 leads to loss of ciliary movement, contributing to disorders such as primary ciliary dyskinesia, abnormal organ positioning (situs inversus), and male infertility via sperm flagella dysmotility[1][2][4][5]. The function and disease relevance of CCDC40 are highly conserved across vertebrate species[3][5]. No direct therapeutic modulation of CCDC40 is available; clinical management relies on symptomatic relief and genetic counseling for affected families[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 40 (CCDC40).